Portfolio of Immunotherapy Stocks (2022)

We have compiled a portfolio of over 140 publicly-traded immunotherapy stocks of companies (as of 2022) that are developing immunotherapies for cancer and treatments for infectious diseases, autoimmune diseases, and more. The stocks associated with these biotechnology companies are traded on the New York Stock Exchange and the NASDAQ Exchange.

This table lists all of the immunotherapy stocks based on alphabetical order. We have provided links to the website of each company and also to dedicated pages with fundamentals and technical analysis data for each ticker. You can learn more about these ImmunoBiotech companies and their upcoming catalysts on the ImmunoFrontiers ImmunoBiotech Viewspace. Note that the table can be sorted by clicking on headings and searched using the search bar.

Interested in investing? Receive $5 by signing up for Acorns.

Learn about the latest news from the ImmunoBiotech space.

Generated by wpDataTables